Boston University School of Medicine is a clinical research site located in Boston, Massachusetts, United States 02118.
Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Boston University School of Medicine has participated in 130 clinical trials with 12 currently active.
Therapeutic areas: Primary Amyloidosis, Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic.
Sponsors: Prothena Biosciences Ltd., Amgen, Boston University.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Massachusetts · View every site in Boston
Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Boston University School of Medicine has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Boston University School of Medicine has 130 clinical trials on record, with 12 currently active. Their work covers Primary Amyloidosis, Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic.
Boston University School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.